1. Single-Cell Diagnosis of Cancer Drug Resistance through the Differential Endocytosis of Nanoparticles between Drug-Resistant and Drug-Sensitive Cancer Cells
   Lingshan Liu et al, 2023, ACS Nano CrossRef
2. MFS transporters required for multidrug/multixenobiotic (MD/MX) resistance in the model yeast: understanding their physiological function through post-genomic approaches
   Sandra C. dos Santos et al, 2014, Frontiers in Physiology CrossRef
3. Sustained Epigenetic Drug Delivery Depletes Cholesterol–Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids
   Vijay Raghavan et al, 2015, Langmuir CrossRef
4. Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
   Daruka Mahadevan et al, 2004, Blood CrossRef
5. Comparative lipidomics of 5-Fluorouracil–sensitive and –resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1)
   Jae Hun Jung et al, 2020, Scientific Reports CrossRef
6. Breaking Down Tumor Drug Resistance: The Link Between Cell Membrane Changes and Treatment Efficacy
   Neelabh Datta, 2023, Acta Biologica Marisiensis CrossRef
7. Progresses of Cell Membrane Fluidity and Permeability Affecting Drug Resistance in Tumor
   翔 朱, 2020, Advances in Clinical Medicine CrossRef